Shareholder Class Action
Directors are selling Envision Healthcare Corp. too cheaply through an unfair process to KKR entities, for $9.9 billion or $46 a share, shareholders say in a federal class action.
Read moreShareholder Class Action
Shareholder Class Action
Shareholders claim directors of Foundation Medicine filed a false and misleading registration statement about its proposed sale to Roche Pharmaceuticals, for $137 a share or $2.4 billion, in a federal class action.
Read more
Crytopcurrency Firm Failed to Register Offerings with SEC, Class Claims
(CN) – Shareholders claim in a class action that Ripple Labs Inc. and its subsidiary, XRP II LLP, sold unregistered
Read moreFox-Disney Merger
A Twenty-First Century Fox shareholder brought a federal class action Tuesday to block the company’s $71.3 billion merger with Disney, saying the deal “omits or misrepresents material information.”
Read more
Columbia Pipeline Execs Orchestrated Sale to Trigger ‘Golden Parachute’ Payments, Class Claims
(CN) – Former stockholders of the Columbia Pipeline Group Inc. claim in a class action that company executives orchestrated a
Read moreBoeing Merger
Directors are selling the parts and services firm KLX Inc. too cheaply through an unfair process to Boeing, for $63 a share or $3.25 billion, shareholders say in a federal class action.
Read moreShareholder Class Action
Directors are selling ILG Inc. too cheaply through an unfair process to Marriott Vacations Worldwide, for $4.7 billion, shareholders say in a federal class action.
Read moreShareholder Class Action
Columbia Pipeline Group shareholders claim in court that directors forced a sale to TransCanada through an unfair, self-interested process, for $25.50 a share or $13 billion.
Read moreSouth African Gold Miner Sued Over Mounting Fatalities
A world leader in gold mining recorded its 21st death this year because the South African company puts profits ahead of safety, Sibanye Gold Limited shareholders said Thursday in a federal class action.
Read moreShareholder Class Action
In a federal class action, shareholders say directors are selling Abaxis (medical devices) too cheaply through an unfair process to Zoetis, for $83 a share or $2 billion.
Read more$23 Billion Merger
Shareholders claim directors are selling Andeavor too cheaply through an unfair process to Marathon Petroleum Corp., for $152.27 a share or 1:1.87 shares, in a federal class action challenging the $23 billion merger.
Read more$3 Billion Merger
Shareholders say in a federal class action that directors are selling Financial Engines (financial advisers) too cheaply through an unfair process to (nonparties) Hellman & Friedman/Edelman Financial Services, for $45 a share or $3 billion.
Read more
Shareholders Decry FAT Brands After Post-IPO Stock Plunge
(CN) – Shareholders launched a securities class action against FAT Brands Inc., claiming the company misrepresented the financial strength of
Read more
11th Circuit Reverses Lower Court on Raymond James Class Action
(CN) – A proposed class action against Raymond James & Associates claiming the company kept profits from processing fees is not precluded by federal law, the 11th Circuit ruled.
Read morePG&E Class Action
Shareholders claim in a federal class action that the price of PG&E stock fell from $44.66 to $42.34 this spring after Cal Fire officials found PG&E responsible for eight of the 12 deadly North Bay wildfires that burned 245,000 acres in October 2017.
Read morePatent-Risk Management
Shareholders say in a federal class action that directors are selling RPX Corp., a provider of patent-risk and discovery-management solutions, too cheaply through an unfair process to the private-equity firm HGGC LLC, for $10.50 a share or $555 million.
Read more
Verifone’s Go-Private Deal Falls Flat for Shareholders, Class Claims
(CN) – Verifone Systems’ plan to take the company private in a deal valued at $3.4 billion spurred a class
Read more
Class Sues Micro Focus After Merger With HP Spinoff
(CN) – British software firm Micro Focus International overstated the benefits of a proposed merger with Hewlett Packard spinoff HPE
Read more$1.6 Billion Merger
Directors are selling Armo Biosciences too cheaply through an unfair process to Eli Lilly, for $50 a share or $1.6 billion, shareholders say in a federal class action.
Read moreLongfin Crashes
Longfin shares crashed from $71.10 to $5.05 this year, and the cryptocurrency was booted from the NASDAQ, shareholders claim in a federal class action.
Read more